Skip to main content
. 2017 Dec 14;8(70):115230–115243. doi: 10.18632/oncotarget.23247

Figure 2. cfDNA concentration levels and metabolic syndrome components.

Figure 2

(A) Average of cfDNA content in patients younger and older than 65 years old. (B) Correlation of age with EC grading. (C) CfDNA content association with body mass index (BMI) <30 and > 30. (D) Correlation analysis of cfDNA amount in serum samples from non-hypertensive (no hyp) and hypertensive (hyp) EC patients. Statistical significance: *P≤0.05, **P≤0.01, ***P≤0.001. Data are represented as mean +/− standard error (SEM). The error bars indicate the standard error. (E) Receiver operative characteristics (ROC) curves for cfDNA levels discriminating between hypertensive and non- hypertensive patients, patients with BMI ≥ 30 and with BMI < 30, and aged ≥65 and aged < 65 years.